rs34936112
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_019892.6(INPP5E):c.1280-24C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.282 in 1,436,530 control chromosomes in the GnomAD database, including 59,794 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.25 ( 5216 hom., cov: 33)
Exomes 𝑓: 0.29 ( 54578 hom. )
Consequence
INPP5E
NM_019892.6 intron
NM_019892.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.118
Publications
9 publications found
Genes affected
INPP5E (HGNC:21474): (inositol polyphosphate-5-phosphatase E) The protein encoded by this gene is an inositol 1,4,5-trisphosphate (InsP3) 5-phosphatase. InsP3 5-phosphatases hydrolyze Ins(1,4,5)P3, which mobilizes intracellular calcium and acts as a second messenger mediating cell responses to various stimulation. Studies of the mouse counterpart suggest that this protein may hydrolyze phosphatidylinositol 3,4,5-trisphosphate and phosphatidylinositol 3,5-bisphosphate on the cytoplasmic Golgi membrane and thereby regulate Golgi-vesicular trafficking. Mutations in this gene cause Joubert syndrome; a clinically and genetically heterogenous group of disorders characterized by midbrain-hindbrain malformation and various associated ciliopathies that include retinal dystrophy, nephronophthisis, liver fibrosis and polydactyly. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2016]
INPP5E Gene-Disease associations (from GenCC):
- Joubert syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), G2P
- MORM syndromeInheritance: AR Classification: DEFINITIVE, MODERATE, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, G2P, Genomics England PanelApp, ClinGen, Orphanet
- COACH syndrome 1Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Joubert syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Joubert syndrome with ocular defectInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 9-136432610-G-A is Benign according to our data. Variant chr9-136432610-G-A is described in ClinVar as [Benign]. Clinvar id is 261191.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.301 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.254 AC: 38623AN: 151972Hom.: 5215 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
38623
AN:
151972
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.257 AC: 39111AN: 152366 AF XY: 0.251 show subpopulations
GnomAD2 exomes
AF:
AC:
39111
AN:
152366
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.285 AC: 366135AN: 1284440Hom.: 54578 Cov.: 19 AF XY: 0.282 AC XY: 180019AN XY: 638958 show subpopulations
GnomAD4 exome
AF:
AC:
366135
AN:
1284440
Hom.:
Cov.:
19
AF XY:
AC XY:
180019
AN XY:
638958
show subpopulations
African (AFR)
AF:
AC:
5222
AN:
29390
American (AMR)
AF:
AC:
10339
AN:
35562
Ashkenazi Jewish (ASJ)
AF:
AC:
7923
AN:
24428
East Asian (EAS)
AF:
AC:
3137
AN:
35334
South Asian (SAS)
AF:
AC:
13204
AN:
77236
European-Finnish (FIN)
AF:
AC:
11712
AN:
44422
Middle Eastern (MID)
AF:
AC:
1366
AN:
5478
European-Non Finnish (NFE)
AF:
AC:
298354
AN:
978200
Other (OTH)
AF:
AC:
14878
AN:
54390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
12273
24545
36818
49090
61363
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.254 AC: 38642AN: 152090Hom.: 5216 Cov.: 33 AF XY: 0.250 AC XY: 18609AN XY: 74348 show subpopulations
GnomAD4 genome
AF:
AC:
38642
AN:
152090
Hom.:
Cov.:
33
AF XY:
AC XY:
18609
AN XY:
74348
show subpopulations
African (AFR)
AF:
AC:
7578
AN:
41508
American (AMR)
AF:
AC:
4548
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
1113
AN:
3466
East Asian (EAS)
AF:
AC:
284
AN:
5174
South Asian (SAS)
AF:
AC:
822
AN:
4828
European-Finnish (FIN)
AF:
AC:
2659
AN:
10574
Middle Eastern (MID)
AF:
AC:
82
AN:
294
European-Non Finnish (NFE)
AF:
AC:
20688
AN:
67936
Other (OTH)
AF:
AC:
582
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1460
2920
4379
5839
7299
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
511
AN:
3476
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.